- Plus Therapeutics (NASDAQ:PSTV) +99% on BARDA payment.
- Avadel Pharmaceuticals plc (NASDAQ:AVDL) +33% after FDA approves REST-ON trial amendment.
- Arotech (NASDAQ:ARTX) +32% on being acquired by Greenbriar.
- Mallinckrodt plc (NYSE:MNK) +18% on positive StrataGraft data.
- Viveve Medical (NASDAQ:VIVE) +10%.
- PolarityTE (NASDAQ:PTE) +10% on positive SkinTE data.
- Intec Pharma (NASDAQ:NTEC) +7%.
- Yuma Energy (NYSEMKT:YUMA) +6%.
- Endeavour Silver (NYSE:EXK) +6%.
- ZIOPHARM Oncology (NASDAQ:ZIOP) +6%.
- Exact Sciences (NASDAQ:EXAS) +5% as FDA OKs Exact's Cologuard for younger people.